Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe Mounjaro injection is a once-weekly subcutaneous injection of tirzepatide, a prescription medicine licensed in the UK for weight management in adults. It comes as a pre-filled KwikPen — each pen contains four weekly doses — and works by activating two gut-hormone receptors simultaneously to reduce appetite and slow gastric emptying. As a prescription-only medicine, it can only be obtained following a clinical assessment by a qualified prescriber, who will decide whether it is appropriate for you personally. The sections below walk through exactly what the injection is, how to use it step by step, which side effects to watch for, and who the treatment is licensed for.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Before the pen is in your hands, a prescriber has to conclude it is right for you. That assessment covers your BMI, your health history, any medicines you take, and whether a weight-related condition raises your clinical need. The licensed eligibility is a BMI of 30 or above, or 27 or above alongside at least one condition such as high blood pressure, high cholesterol, obstructive sleep apnoea or type 2 diabetes. Lower BMI thresholds can apply for some ethnic backgrounds under UK guidance.
One thing worth gently setting aside: a lot of people assume the injection itself is the complicated part. In practice, the clinical decision that precedes it is the part that takes real care. The KwikPen is designed to be straightforward for self-administration at home, and if you are considering the Synedica tirzepatide pen as an alternative device option, that page covers how it compares. If you are curious about what the pen looks like before committing to a consultation, the overview of Mounjaro injection pens covers the device in detail.
Once a prescriber at a GPhC-registered pharmacy is satisfied, a prescription is issued, the pen is dispensed, and you receive the Patient Information Leaflet that accompanies every pack. That leaflet is the primary reference for the exact steps that follow, reading it before your first injection is not a formality, it is genuinely useful.
Mounjaro is injected once weekly, on the same day each week where possible, into the fatty tissue just beneath the skin. The three approved sites are the abdomen, the outer thigh, and the upper arm. Rotating between sites matters, using the same spot repeatedly can affect how the medicine is absorbed and may cause skin reactions. A practical guide to rotating correctly is in our injection site guide.
Before injecting, wash your hands. If you are using an alcohol swab to clean the skin first, let it dry fully before pressing the pen to the site, damp skin makes the process less comfortable. For a full walkthrough of the administration process, our guide to the Mounjaro injection covers each step in detail, including what to do if something feels uncertain the first time. The KwikPen clicks when pressed against the skin and held in place; you hold it there until the injection is complete, which the pen signals. Needles should be changed with every injection. A pack of compatible needles makes it straightforward to keep a supply at home.
Used needles and pens count as sharps waste and cannot go into household recycling. Your local pharmacy or GP surgery can advise on disposal, and a sharps container keeps them safe between collections. Storage is in the fridge at 2–8°C; for the precise room-temperature window permitted before use, consult the Patient Information Leaflet or the Mounjaro SmPC on the eMC, that window does vary by circumstance and should not be guessed.
The 2.5 mg starting dose has one job: letting your body acclimatise. It is not the dose at which most people experience meaningful weight loss; the prescriber will review your progress and tolerance before any change. This staged approach is why the titration schedule exists, rushing through it increases the chance of side effects without adding benefit.
Those side effects are mainly gastrointestinal. Nausea is the most commonly reported, alongside looser stools, constipation in some people, indigestion, and occasional burping. They are most pronounced in the first few days after a new dose, and most people find they settle considerably within a couple of weeks. Eating smaller portions, avoiding very fatty or spicy meals, and staying well hydrated all help. Fatigue and mild headaches are also reported, particularly early on.
Two symptoms need prompt medical attention rather than watchful waiting: severe stomach pain that spreads towards the back (a possible sign of pancreatitis, flagged in the MHRA's January 2026 Drug Safety Update on GLP-1 medicines), and any signs of a serious allergic reaction such as swelling or breathing difficulty. The NHS patient information page on tirzepatide lists the full range of side effects and the thresholds for seeking help. If you notice something unexpected and are unsure, the Yellow Card scheme at yellowcard.mhra.gov.uk allows patients to report suspected reactions directly to the MHRA.
Using Mounjaro at home week after week is routine quickly. A few practical points are worth knowing before you start. If you plan to travel, the pen needs to stay refrigerated, and some travel insurance policies ask about prescription medicines, it is worth understanding the implications for travel insurance before you fly. And if you ever want to understand how private Mounjaro pricing is structured across providers, the Mounjaro price comparison page gives a factual, jargon-free breakdown of what drives the cost difference between services.
Ongoing clinical oversight matters as much as the injection technique. Every repeat prescription should involve a review of your progress, not just a rubber-stamp. That is why, at nume, a real prescriber reads your update before each repeat, and the clinical team page explains who is doing that review. Treatment is one part of the picture; the lifestyle changes that support it are the other.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.